
- Pharmaceutical Commerce - September/October 2017
EMA entertains relocation bids, readies a business-continuity plan
New location, following Brexit, will be decided in November
One of the first realizations following the Brexit vote in the UK last year was that the European Medicines Agency, which recently had centralized its operations in London, would need to leave—and leave quickly. Since then the agency has readied a relocation plan, and on August 1 announced that 19 cities within the EU had submitted bids to be the new home. (The
In terms of physical movement, EMA is a relatively small agency, with a staff of around 900 (FDA, by comparison, is 15,000—not all of whom are at the White Oak, MD, headquarters.) EMA is set up to coordinate activities of the health agencies of its member states; there are some 4,500 experts on call, for example, to assist in drug evaluations. To ensure business continuity, EMA has
The siting of EMA is an economic plum regardless of its staff size, notes Rory Mullen, VP for Biopharma and Food at IDA Ireland (the country’s economic development authority). The coordinating nature of its operations means a high number of visits to the headquarters, a boon for travel and lodging. Dublin, Ireland’s bid for the new location, has the advantages of being in a country with a high concentration of biopharma activity today; in addition, he points out, Ireland will be the only English-dominant-speaking nation within the EU after Brexit, which could be a factor for streamlining coordination between EMA and other global agencies including, obviously, FDA.
Articles in this issue
about 8 years ago
Patient data saves livesabout 8 years ago
MDM’s growing role in running healthcare businessesabout 8 years ago
The power of strategic data standardizationabout 8 years ago
2017 Cold Chain Outlookabout 8 years ago
Cold Chain 2017 Directoryabout 8 years ago
Is the opioid crisis a national emergency?about 8 years ago
It’s time for an industry guideline on patient support servicesabout 8 years ago
A conversation with Greg Flynn, Ashfield Healthcare USabout 8 years ago
LogiPharma meeting highlights digital transformationNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.